Top Markets
#1 Helium Helium +53.03%
#2 TENDIES TENDIES +40.70%
#3 Pons Pons +22.44%
#4 Seeker Seeker +21.43%
#5 Songbird Songbird +13.20%
#6 pipedog pipedog +12.93%
#7 UnifAI Network UnifAI Network +12.62%
#8 StonkBroker StonkBroker +11.14%
#9 OSK OSK +9.90%
#10 Wrapped STX (Velar) Wrapped STX (Velar) +8.92%
Coin of the day
Helium Helium
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
HPGC Renmintongtai Pharmaceutical Corporation HPGC Renmintongtai Pharmaceutical Corporation

HPGC Renmintongtai Pharmaceutical Corporation

600829
Kedudukan dalam Saham #10252
HPGC Renmintongtai Pharmaceutical Corporation is a pharmaceutical enterprise... HPGC Renmintongtai Pharmaceutical Corporation is a pharmaceutical enterprise actively involved in the wholesale and retail distribution of diverse medicinal products across China and internationally. Its extensive product portfolio encompasses traditional Chinese medicines, herbal remedies, chemical preparations, antibiotics, biologics, biochemical drugs, medical equipment, and health-related items. The company also extends its operations to include logistics services, specifically warehousing and distribution. Additionally, it offers comprehensive hospital services covering medical treatment, scientific research, disease prevention, health promotion, rehabilitation, blood purification, and renal disease management. Through its e-commerce platform, HPGC Renmintongtai markets a broad selection of items, including Chinese and Western pharmaceuticals, traditional Chinese herbs, nutritional supplements, medical devices, cosmetics, and everyday necessities. The company maintains a significant retail presence with 319 chain stores located throughout Heilongjiang Province. Established in 1950 and headquartered in Harbin, China, HPGC Renmintongtai Pharmaceutical Corporation operates as a subsidiary of Harbin Pharmaceutical Group Co., Ltd.
Harga Saham
$1.49
Disegerakkan terakhir: 2026-08-28
Modal Pasaran
$866.39M
Perubahan (1 hari)
-2.55%
Perubahan (1 tahun)
30.24%
Negara
CN
Perdagangan HPGC Renmintongtai Pharmaceutical Corporation (600829)

Kategori

Healthcare
Pendapatan untuk HPGC Renmintongtai Pharmaceutical Corporation (600829)
Pendapatan pada 2026 TTM: 0
Menurut laporan kewangan terkini HPGC Renmintongtai Pharmaceutical Corporation, pendapatan semasa syarikat ialah 0. Pada tahun 2026, syarikat memperoleh pendapatan sebanyak 0, sama dengan pendapatan pada tahun 2026 yang berjumlah 0. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi HPGC Renmintongtai Pharmaceutical Corporation dari 2026 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
Tidak cukup data untuk tarikh yang disediakan.
Pendapatan untuk syarikat atau pesaing serupa
Syarikat Pendapatan Perbezaan Pendapatan Negara
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
- -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
- -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
- -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
- -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
$1.76B -
IN